Abstract |
|
Authors | Y Hasegawa, T Itoh, Y Tamagawa, T Komeno, H Kojima, H Ninomiya, Y Yatabe, N Mori, T Nagasawa |
Journal | Leukemia & lymphoma
(Leuk Lymphoma)
Vol. 35
Issue 5-6
Pg. 613-8
(Nov 1999)
ISSN: 1042-8194 [Print] United States |
PMID | 10609800
(Publication Type: Case Reports, Comparative Study, Journal Article)
|
Chemical References |
- Dexamethasone
- Doxorubicin
- Cyclophosphamide
- Cisplatin
- Vindesine
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Autoimmune Diseases
(complications)
- Cisplatin
(administration & dosage)
- Clone Cells
(pathology)
- Combined Modality Therapy
- Cyclophosphamide
(administration & dosage)
- Dexamethasone
(administration & dosage)
- Doxorubicin
(administration & dosage)
- Female
- Gene Rearrangement, B-Lymphocyte
- Humans
- Lymphoma, Non-Hodgkin
(drug therapy, pathology)
- Middle Aged
- Neoplasms, Second Primary
(pathology, radiotherapy, surgery)
- Neoplastic Stem Cells
(pathology)
- Plasmacytoma
(pathology, radiotherapy, surgery)
- Radiotherapy, Adjuvant
- Remission Induction
- Thyroid Neoplasms
(drug therapy, pathology, surgery)
- Thyroidectomy
- Thyroiditis, Autoimmune
(complications)
- Vindesine
(administration & dosage)
|